ea0078p46 | Obesity | BSPED2021
Williams Georgina
, Easter Shelley
, Langton Hewer Simon C
, Shield Julian P. H.
, Giri Dinesh
Introduction: The management of childhood obesity is complex and requires intensive input from a multidisciplinary team. Pharmaceutical interventions may be required in addition to lifestyle modifications to treat morbid obesity. In a double blind randomised controlled trial, liraglutide, a glucagon-like peptide 1 (GLP-1) agonist along with dietary and lifestyle interventions showed beneficial BMI reduction in children and adolescents. We present a morbidly obese adolescent wi...